Friday, March 29, 2019
The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the Prior Authorization requirements for Buprenorphine containing drug products and Vivitrol.
dhcf
Department of Health Care Finance - DHCF
Learn about important changes to the Alliance/ICP Program effective October 1, 2025. Visit dhcf.dc.gov/alliance-program-changes for information.
